NEW YORK, NY / ACCESSWIRE / October 19, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Staar Surgical Company (NASDAQ:STAA)
CONTACT JAKUBOWITZ ABOUT STAA:
https://claimyourloss.com/securities/staar-surgical-company-loss-submission-form/?id=10274&from=1
Class Period : February 26, 2020 - August 10, 2020
Lead Plaintiff Deadline : October 19, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: the Company was overstating and/or mischaracterizing: (1) its sales and growth in China; (2) its marketing spend; (3) its research and development expenses; and that as a result of the foregoing, (4) Defendants' public statements were materially false and misleading at all relevant times.
Anaplan Inc. (NYSE:PLAN)
CONTACT JAKUBOWITZ ABOUT PLAN:
https://claimyourloss.com/securities/anaplan-inc-loss-submission-form/?id=10274&from=1
Class Period : November 21, 2019 - February 26, 2020
Lead Plaintiff Deadline : October 23, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was undergoing sales organization and execution challenges; (2) these organizational challenges were causing the Company to miss on closing very important large deals; and (3) as a result, Anaplan's financial guidance for "calculated billings growth" was baseless and unattainable. Further, while in possession of this material non-public information, Anaplan insiders dumped approximately $30 million worth of Anaplan stock at artificially inflated prices.
Royal Caribbean Cruises Ltd. (NYSE:RCL)
CONTACT JAKUBOWITZ ABOUT RCL:
https://claimyourloss.com/securities/royal-caribbean-cruises-ltd-loss-submission-form/?id=10274&from=1
Class Period : February 4, 2020 - March 17, 2020
Lead Plaintiff Deadline : December 7, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Royal Caribbean misled investors to believe that any issue related to COVID-19 was relatively insignificant; (2) the Company falsely assured investors that bookings outside China were strong with no signs of a slowdown; (3) the Company was experiencing material declines in bookings globally due to customer concerns over COVID-19; and (5) the Company's ships were following grossly inadequate protocols that would foster the spread of COVID-19 and pose a substantial risk to passengers and crews.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law